ENTITY
SMARTSCORE: 3.8/5
3SBio Inc

3SBio Inc (1530 HK)

130
Analysis
Health Care • China
3SBio, Inc. is a biotechnology company located in China. The Company focuses on mammalian cell-based biopharmaceuticals in the biotechnology industry. 3SBio also develops, manufactures and markets biopharmaceutical products globally.
more
•03 Aug 2016 11:56

Chinese Choose Not to Have More Children

Chinese people are actively choosing not to have further children and this will lead inexorably to a population collapse during the balance of this...

Logo
305 Views
Share
•17 Mar 2016 10:00

Just What the Doctor Ordered

This is a quick update on Kemp Dolliver's previous insight "Who's Optimistic About Pharmacy's Future in China? China Nepstar's Controlling...

Share
•25 Feb 2016 21:38

Coming to the HKEX Soon....................

Bloomberg has published a story (that others have cited) that WuXi Pharmatech has picked bankers for an HK listing of its biologics manufacturing...

Share
•18 Feb 2016 15:01

Time to Go Shopping for Healthcare

The decline in equity markets has created opportunities to buy a variety of healthcare stocks at attractive valuations. Insider purchases have...

Share
bullish•3SBio Inc
•27 Jan 2016 02:48

China's FDA Ups Its Game

One of the pharmaceutical industry’s main complaints about China is the extremely slow drug approval process. The approval process in China...

Share
x